Here, however, we focus on pre-clinical experimentation in which the effects of HDAC inhibitors have been studied in rodent models of diabetes, without other comorbidity, and we have thus chosen to employ the term “diabetic kidney disease”. Here, HDAC9 is linked to diabetes mellitus.